You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

List of Excipients in API fosdenopterin hydrobromide

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing fosdenopterin hydrobromide

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sentynl Therapeutics Inc	NULIBRY	fosdenopterin hydrobromide	42358-295	ASCORBIC ACID	2029-04-09
Sentynl Therapeutics Inc	NULIBRY	fosdenopterin hydrobromide	42358-295	HYDROCHLORIC ACID	2029-04-09
Sentynl Therapeutics Inc	NULIBRY	fosdenopterin hydrobromide	42358-295	MANNITOL	2029-04-09
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for fosdenopterin hydrobromide

Excipient focus: ASCORBIC ACID

fosdenopterin hydrobromide drug variants containing ASCORBIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sentynl Therapeutics Inc	fosdenopterin hydrobromide	42358-295
Origin Biosciences Inc	fosdenopterin hydrobromide	73129-001
>Company	>Ingredient	>NDC

fosdenopterin hydrobromide drug variants not containing ASCORBIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

fosdenopterin hydrobromide drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sentynl Therapeutics Inc	fosdenopterin hydrobromide	42358-295
Origin Biosciences Inc	fosdenopterin hydrobromide	73129-001
>Company	>Ingredient	>NDC

fosdenopterin hydrobromide drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

fosdenopterin hydrobromide drug variants containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sentynl Therapeutics Inc	fosdenopterin hydrobromide	42358-295
Origin Biosciences Inc	fosdenopterin hydrobromide	73129-001
>Company	>Ingredient	>NDC

fosdenopterin hydrobromide drug variants not containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

fosdenopterin hydrobromide drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sentynl Therapeutics Inc	fosdenopterin hydrobromide	42358-295
Origin Biosciences Inc	fosdenopterin hydrobromide	73129-001
>Company	>Ingredient	>NDC

fosdenopterin hydrobromide drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCROSE

fosdenopterin hydrobromide drug variants containing SUCROSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sentynl Therapeutics Inc	fosdenopterin hydrobromide	42358-295
Origin Biosciences Inc	fosdenopterin hydrobromide	73129-001
>Company	>Ingredient	>NDC

fosdenopterin hydrobromide drug variants not containing SUCROSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.